Abstract
A number of common metastatic cancers are associated with marked weight loss at the time of diagnosis. Cancer patients with weight loss at the time of diagnosis have decreased mean survival compared to similar cancer patients without weight loss. Provision of excess calories alone does not appear to change median survival in patients with advanced cancer and many patients either maintain body weight or lose weight while receiving calories which would be predicted to result in weight gain. We have recently extended our studies to head and neck cancer patients without detectable metastatic disease in order to detect systemic metabolic effects of a localized tumor. These patients failed to gain weight despite the administration of apparently adequate calories by continuous enteral alimentation. Abnormalities of carbohydrate metabolism with secondary effects on fat and protein metabolism have been identified in several populations of patients with common cancers. These abnormalities offer potential points of intervention which may enhance nutritional therapy as rehabilitation and as a potential biological modifier of the response of specific cancers to chemotherapy, radiation therapy or surgery.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bergman RN, Phillips LS, Cobelli C: Physiologic evaluation of factors controlling glucose tolerance in man, measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose. J Clin Invest 68:1456, 1981
Brennan MF: Total parenteral nutrition in the cancer patient. New Engl J Med 305:375, 1981
Burt ME, Stein PT, Schwade JG, Brennan MF: Whole body protein metabolism in cancer-bearing man: effect of total parenteral nutrition and associated insulin response. Cancer 53:1246, 1984
Chlebowski RT, Heber D, Block JB: Serial assessment of glucose metabolism in patients with cancer cachexia. (Abst.) Clin Res 30:69A, 1982
Chlebowski RT, Heber D, Richardson B, Block JB: Influence of hydrazine sulfate on abnormal carbohydrate metabolism in cancer patients with weight loss. Cancer Res 44:857, 1984
Copeland EM: Intravenous hyperalimentation and chemotherapy: an update. JPEN 6:236, 1982
Copeland EM, Macfayder BV, Dudrick SJ: Effect of hyperalimentation on established delayed hypersensitivity in the cancer patient. Ann Surg 184:60, 1976
Costa G, Bewley P, Aragon M, Siebold J: Anorexia and weight loss in cancer patients. Cancer Treat Rep 65:131, 1981
De Wys D, et al.: Prognostic effect of weight loss prior to chemotherapy in cancer patients. Am J Med 69:491, 1980
Eden E, Edstrom S, Bennegard K, Schersten T, Lundholm K: Glucose flux in relation to energy expenditure in malnourished patients with and without cancer during periods of fasting and feeding. Cancer Res 44:1717, 1984
Fassina G: Mechanisms of lipid mobilization. Adv Exp Biol Med 109:209, 1978
Frederick G, Begg RW: Development of lipidemia during tumor growth in the rat. Proc AACR 1:8, 1954
Heber D, Byerley LO, Chlebowski RT: Metabolic abnormalities in the cancer patient. Cancer 55:225, 1985
Heber D, Chlebowski RT, Ishibashi DE, Herrold JN, Block JB: Abnormalities in glucose and protein metabolism in noncachectic lung cancer patients. Cancer Res 42:4815, 1982
Holroyde CP, Reichard GA: Carbohydrate metabolism in cancer cachexia. Cancer Treat Rep 65:55, 1981
Holroyde CP, Gabuzda G, Putnam RC, et al.: Altered glucose metabolism in metastatic cancer. Cancer Res 35:3710, 1975
Issel BF, Valdivieso M, Zaren HA, et al.: Protection against chemotherapy toxicity by IV hyperalimentation. Cancer Treat Rep 62:1139, 1978
Jordan W, Valdivieso M, Frankmann C, et al.: Treatment of advanced adenocarcinoma of the lung with ftorafur, doxorubicin, cyclophosphamide, and cisplatin (FACP) and intensive IV hyperalimentation. Cancer Treat Rep 65:197, 1981
Kitada S, Hays EF, Mead JF: Lipid mobilizing factor in serum of tumor-bearing mice. Lipids 15:168, 1980
Kitada S, Hays EF, Mead JF, Zabin I: Lipolysis induction in adipocytes by a protein from tumor cells. J Cell Biochem 20:409, 1982
Kitada S, McAndrew PF, Elepano MG, Gutherie B, Hays EF, Mead JF: Lipid mobilizing factor in the serum of cancer patients. Proc AACR 25:155, 1984
Liebelt RA: Lipid mobilization and food intake in experimentally obese mice, bearing transplanted tumor. Proc Soc Exp Biol Med 138:482, 1971
Liebelt RA, Gehring L: Paraneoplastic syndromes in experimental animal model systems. Ann NY Acad Sci 230:547, 1974
Lundholm K, Edstrom S, Eckman L: Comparative study of influence of tumor on host metabolism in mice and men. Cancer 42:453, 1978
Lundholm K, Edstrom S, Eckman L, Karlberg I, Schersten I: Metabolism in peripheral tissues in cancer patients. Cancer Treat Rep 65(Suppl. 5):79, 1981
Lundholm K, Edstrom S, Karlberg I, Ekman L, Schersten T: Glucose turnover, gluconeogenesis from glycerol, and estimation of net glucose cycling in cancer patients. Cancer 50:1142, 1982
Masuno H, Yamasaki N, Okuda H: Purification and characterization of a lipolytic factor (toxohormone-L) from a cell-free fluid of ascites sarcoma 180. Cancer Res 41:284, 1981
Masuno H, Yamasaki N, Okuda H: Isolation of a lipolytic factor (toxohormone-L) from ascites fluid of patients with hepatoma and its effects on feeding behavior. Eur J Ca Clin Onc 20:1177, 1984
Moley JF, Morrison SD, Norton JA: Insulin reversal of cancer cachexia in rats, Cancer Res 45:4925, 1985
Mueller PS, Watkin D: Plasma unesterified fatty acid concentrations in neoplastic disease. J Lab Clin Med 57:95, 1961
Nakahara W: A chemical basis for tumor host relations. J Nat Cancer Inst 24:77, 1960
Nakahara W, Fukuoka F: Toxohormone. JAPMJ 1:271, 1948
Nixon D, Heymsfield S: personal communication.
Nixon DW, Moffitt S, Lawson DH, et al.: Total parenteral nutrition as an adjunct to chemotherapy of metastatic colorectal cancer. Cancer Treat Rep 65:121, 1981
Odell WD, Wolfsen AR: Hormones from tumors: are they ubiquitous? Am J Med 68:317, 1980
Popp MB, Fischer RI, Wesley R, et al.: A prospective randomized study of adjuvant parenteral nutrition in the treatment of advanced diffuse lymphoma: influence on survival. Surgery 90:195, 1981
Randle PJ, Garland P, Hales C, Newsholme EA: The glucose fatty acid cycle. Lancet 1:785, 1963
Samuels ML, Selig DE, Ogden S, et al.: IV hyperalimentation and chemotherapy for stage II testicular cancer: a randomized study. Cancer Treat Rep 68:615, 1978
Schein PS, Kisner D, Haller D et al.: Cachexia of malignancy: potential role of insulin in institutional management. Cancer 49:2070, 1979
Terepka AR, Waterhouse C: Metabolic observations during forced feeding of patients with cancer. Am J Med 20:225, 1956
Todaro GJ, DeLarco JE, Fryling C, Johnson PA, Sporn MB: Transforming growth factors: Properties and possible mechanisms of activity. J Supramol Struct Cell Bioch 15:287, 1981
Trew JA, Begg RW: In vitro incorporation of acetate 1–14C into adipose tissue from normal and tumor bearing rats. Cancer Res 19:1014, 1959
Warren S: The immediate cause of death in cancer. Am J Med Sci 184:610, 1932
Waterhouse C: Oxidation and metabolic interconversion in malignant cachexia. Cancer Treat Rep 65:61, 1981
Young VR: Energy metabolism and requirements in the cancer patient. Cancer Res 37:2336, 1977
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Kluwer Academic Publishers, Dordrecht
About this chapter
Cite this chapter
Heber, D., Byerley, L.O. (1989). Effects of Localized and Disseminated Cancers on Metabolism and Nutrition in Man. In: Levine, A.S. (eds) Etiology of Cancer in Man. Cancer Growth and Progression, vol 6. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-2532-8_7
Download citation
DOI: https://doi.org/10.1007/978-94-009-2532-8_7
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-7644-9
Online ISBN: 978-94-009-2532-8
eBook Packages: Springer Book Archive